Zoloft Birth Defects
The antidepressant Zoloft has been linked to an increased risk of serious and potentially deadly birth defects when taken during pregnancy. Children who are born to women that used Zoloft while pregnant may be up to six times more likely to suffer from heart defects or other congenital birth defects.
According to a 2007 study, pregnant women who are prescribed Zoloft are twice as likely to give birth to a child with heart defects. The most commonly reported heart defects among women who used Zoloft during pregnancy were ventricular outflow defects and septal defects. Women taking Zoloft while pregnant were nearly twice as likely to give birth to a baby suffering from craniosynostosis (sutures in the skull close too early) and six times more likely to give birth to a child with omphalocele (abdominal organs protrude from the belly button).
When taken during the third trimester of pregnancy, Zoloft users are six times more likely to give birth to a child with persistent pulmonary hypertension of the newborn (PPHN). This condition causes circulation problems which make it difficult for oxygen to reach the bloodstream. Although PPHN can be treated with surgery, the condition can cause lifetime developmental difficulties, as well as heart failure, kidney failure, seizures, hemorrhages, organ damage or death.
Children born to Zoloft users may also be at in increased risk of other birth defects, including:
- Hypoplastic Left Heart Syndrome (HLHS)
- Tetralogy of Fallot
- Patent Ductus Arteriosus (PDA)
- Bicuspid Aortic Valve
- Tricuspid Stenosis
- Cleft Mitral Valve
If you or a loved one took Zoloft during pregnancy and gave birth to a child with heart defects like PPHN or other congenital birth defects, contact the lawyers at Hissey Kientz, LLP for a free case evaluation. You can reach us by calling toll-free at 1-866-275-4454, or by filling out our free contact form on the right of this page. Click here to visit the Hissey Kientz, LLP website dedicated to Zoloft birth defects lawsuits and settlement news.